EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Orchestra BioMed Holdings, Inc. (OBIO) had EBITDA of $6.90M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$30.92M
Net Income	$5.99M
Cost of Goods Sold	$0.05M
Gross Profit	$30.87M
Operating Expenses	$24.16M
Operating Income	$6.75M
Non-Operating Income/Expense	$-0.51M
Pre-Tax Income	$6.25M
Normalized Pre-Tax Income	$6.25M
Income after Taxes	$6.25M
Income from Continuous Operations	$6.25M
Consolidated Net Income/Loss	$6.25M
Normalized Income after Taxes	$6.25M
EBIT	$6.75M
EBITDA	$6.90M
Weighted-Average Shares Outstanding (Basic)	47.75M
Weighted-Average Shares Outstanding (Diluted)	47.75M
Earnings per Share (EPS) (Basic)	$0.28
Earnings per Share (EPS) (Diluted)	$0.28
Balance Sheet Financials
Current Assets	$107.91M
Property, Plant, and Equipment	$1.72M
Long-Term Assets	$6.95M
Total Assets	$114.86M
Current Liabilities	$16.74M
Long-Term Debt	$14.27M
Long-Term Liabilities	$44.55M
Total Liabilities	$61.29M
Common Equity	$53.57M
Tangible Shareholders Equity	$53.57M
Shareholders Equity	$53.57M
Common Shares Outstanding	57.03M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-48.96M
Cash Flow from Investing Activities	$-26.94M
Cash Flow from Financial Activities	$88.33M
Beginning Cash	$22.26M
End Cash	$34.69M
Increase/Decrease in Cash	$12.43M
Stock-Based Compensation	$11.98M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	6.45
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.21
Debt to Equity Ratio	0.27
Gross Margin	99.83%
Operating Margin	21.85%
EBIT Margin	21.85%
EBITDA Margin	--
Pre-Tax Profit Margin	20.20%
Profit Margin	19.38%
Free Cash Flow	$-49.45M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.27
Inventory Turnover	0.16
Receiveable Turnover	325.44
Days Sales in Receivables	0.28
Return on Equity	11.66%
Return on Tangible Equity	11.66%
Return on Assets	5.44%
Return on Investments	9.21%
Book Value Per Share	$0.94
Free Cash Flow per Share	$-1.04
Operating Cash Flow per Share	$-1.03

Data from Zacks Investment Research, Inc.